Biographical Sketch of Kiyoshi Nokihara (Doctor of Pharmaceutical Sciences)

摘要

The CEO and CSO of the HiPep Laboratories, Dr. Noki-hara, initially studied Organic Chemistry and Chemical Engineering in Tokyo, followed by many years of academic research in Germany. His involvement with bio-molecules commenced at Deutsches Wollforschungs Institute at the Technis-chen Hochschule Aachen (1973-1979). From 1980 to 1985, he was Assistant Professor of the Faculty of Pharmaceutical Sciences of Shizuoka Prefectural University, where he undertook extensive research on brain-gastrointestinal peptides, syntheses as well as immunochemical and endocrinology studies. He subsequently relocated to the University of Heidelberg in the role of visiting Professor, and later at the GBF (German Research Center for Biotechnology). In 1990 he joined the Biotechnology Instruments Department of the Shimadzu Corporation, as General Manager in R & D and Head of the Life Science Center. He has developed several novel instruments focusing on applications, including the simultaneous multiple automated peptide synthesizer, for which his team received a prize bestowed by the Japanese Agency of Science and Technology. His expertise was focused on the biochemical and medical fields, especially proteins and peptides, from isolation, synthesis and characterization to biochemical and medical applications. As well as his business commitments he received visiting Professor positions at the Tokyo University of Agriculture and Technology and the Tokyo Metropolitan Institute for Neuroscience Research to continue his academic research. In 1997 he founded Shimadzu Scientific Research Inc. and established novel research business as Chief Scientist. In 2002 he has independently founded a new venture company, the HiPep Laboratories, based on his knowledge and experiences in Peptide and Protein Science in addition to instrumentation. He is now a visiting Professor in Nanjing Medical University (China). He has more than 250 publications and 90 patent applications.